1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combined Targeting of JAK2 and Bcl-2/Bcl-xL to Cure Mutant JAK2-Driven Malignancies and Overcome Acquired Resistance to JAK2 Inhibitors
    Journal Article

    Waibel, M.; Solomon, V. S.; Knight, D. A.; Ralli, R. A.; Kim, S. K.; Banks, K. M.; Vidacs, E.; Virely, C.; Sia, K. C. S.; Bracken, L. S.; more...
    Cell Reports (2013)

    Fulltext@MSK | Save
  • Magnetic resonance imaging/positron emission tomography provides a roadmap for surgical planning and serves as a predictive biomarker in patients with recurrent gynecological cancers undergoing pelvic exenteration
    Journal Article

    Vargas, H. A.; Burger, I. A.; Donati, O. F.; Andikyan, V.; Lakhman, Y.; Goldman, D. A.; Schöder, H.; Chi, D. S.; Sala, E.; Hricak, H.
    International Journal of Gynecological Cancer (2013)

    Fulltext@MSK | Save
  • Tackling the diversity of Triple-negative breast cancer
    Journal Article

    Turner, N. C.; Reis-Filho, J. S.
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
    Journal Article

    Toy, W.; Shen, Y.; Won, H.; Green, B.; Sakr, R. A.; Will, M.; Li, Z.; Gala, K.; Fanning, S.; King, T. A.; more...
    Nature Genetics (2013)

    Fulltext@MSK | Save
  • Mass-Encoded, synthetic biomarkers and multiplexed urinary monitoring: New frontiers in disease monitoring
    Journal Article

    Tempst, P.
    Clinical Chemistry (2013)

    Fulltext@MSK | Save
  • Evaluation of arginine deiminase treatment in melanoma xenografts using 18F-FLT PET
    Journal Article

    Stelter, L.; Fuchs, S.; Jungbluth, A. A.; Ritter, G.; Longo, V. A.; Zanzonico, P.; Raschzok, N.; Sauer, I. M.; Bomalaski, J. S.; Larson, S. M.
    Molecular Imaging and Biology (2013)

    Fulltext@MSK | Save
  • TGF-β-Id1 signaling opposes twist1 and promotes metastatic colonization via a mesenchymal-to-epithelial transition
    Journal Article

    Stankic, M.; Pavlovic, S.; Chin, Y.; Brogi, E.; Padua, D.; Norton, L.; Massagué, J.; Benezra, R.
    Cell Reports (2013)

    Fulltext@MSK | Save
  • Site-2 protease substrate specificity and coupling in trans by a PDZ-substrate adapter protein
    Journal Article

    Schneider, J. S.; Reddy, S. P.; Hock, Y. E.; Evans, H. W.; Glickman, M. S.
    Proceedings of the National Academy of Sciences of the United States of America (2013)

    Fulltext@MSK | Save
  • Carbon nanotubes as vaccine scaffolds
    Journal Article

    Scheinberg, D. A.; McDevitt, M. R.; Dao, T.; Mulvey, J. J.; Feinberg, E.; Alidori, S.
    Advanced Drug Delivery Reviews (2013)

    Fulltext@MSK | Save
  • Mouse model of intrahepatic cholangiocarcinoma validates FIG-ROS as a potent fusion oncogene and therapeutic target
    Journal Article

    Saborowski, A.; Saborowski, M.; Davare, M. A.; Druker, B. J.; Klimstra, D. S.; Lowe, S. W.
    Proceedings of the National Academy of Sciences of the United States of America (2013)

    Fulltext@MSK | Save